Back
HFA Premium Access

Safety and efficacy of tolvaptan administration in patients hospitalised for acute decompensated heart failure due to moderate or severe aortic stenosis

Session: Poster Session 2 - Acute Heart Failure– Treatment
Topic: Pharmacotherapy
Speaker: Doctor R. Hata (Kurashiki, JP)
Event: Heart Failure 2018

Congress Presentation

About the speaker

Doctor Reo Hata

Kurashiki Central Hospital, Kurashiki (Japan)
0 follower

11 more presentations in this session

Digoxin and Prognosis of Heart Failure in Older Patients with Preserved Ejection Fraction: Importance of Heart Rate

Speaker: Doctor P. Llacer (Madrid, ES)

Access
Abstract
Thumbnail

Elegibility for sacubitril/valsartan utilization in acute heart failure

Speaker: Associate Professor L. Passos (Salvador, BR)

Access
Abstract
Slides
Thumbnail

Efficacy of Tolvaptan for the first hospitalized patients with acute decompensated heart failure

Speaker: Doctor Y. Suzuki (Nagoya, JP)

Access
Abstract
Slides
Thumbnail

Effects of low dose levosimendan on renal function in patients with advanced heart failure

Speaker: Doctor R. Dierckx (Aalst, BE)

Access
Abstract
Thumbnail

Using Levosimanden in place for unresponsive acute decompensated heart failure to dobutamine

Speaker: Doctor M. Chou (Tainan, TW)

Access
Abstract
Thumbnail

Access the full session

Poster Session 2 - Acute Heart Failure– Treatment

Speakers: Doctor R. Hata, Doctor P. Llacer, Associate Professor L. Passos, Doctor Y. Suzuki, Doctor R. Dierckx...
Access
Thumbnail

About the event

Image

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb